Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06236243 · ClinicalTrials.gov registry record · NA
Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults
A NA study of Cardiovascular Diseases and Vasodilation, sponsored by Korea Ginseng Corporation.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT06236243: Completed NA study of Cardiovascular Diseases and Vasodilation, sponsored by Korea Ginseng Corporation.
NCT06236243 is a NA study of Cardiovascular Diseases and Vasodilation that has completed, run by Korea Ginseng Corporation. The registered enrollment target is 108 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06236243, a NA study of Cardiovascular Diseases and Vasodilation, has completed, sponsored by Korea Ginseng Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
The objectives of this clinical trial are to 1) determine the effect of the TP compared to placebo on blood flow and platelet aggregation, 2) to determine the effect of the TP on cardiovascular health compared to a placebo and 3) to assess the safety and tolerability of the TP in healthy adults.
Primary Outcome
Between placebo and test products, change from baseline to 6 weeks in flow-mediated dilation of the brachial artery.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Korean Red Ginseng Extract Powder 120 mg/tablet
- DIETARY_SUPPLEMENT Korean Red Ginseng Extract Powder 500 mg/tablet
Study Locations (1)
California
- Valiance Clinical Research - Tarzana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2024-01-31 |
| Est. Completion | 2024-09-25 |
| Phase | NA |
What the finished NCT06236243 record still lists
NCT06236243 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06236243 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06236243 about?
NCT06236243 is a clinical study titled "Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults". The objectives of this clinical trial are to 1) determine the effect of the TP compared to placebo on blood flow and platelet aggregation, 2) to determine the effect of the TP on cardiovascular health compared to a placebo and 3) to assess the safety and tolerability of the TP in healthy adults.
What is the current status of trial NCT06236243?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2024-01-31. Estimated completion is 2024-09-25.
What conditions does trial NCT06236243 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Vasodilation, Blood Pressure Disorders, Platelet Aggregation.
What interventions are being tested in trial NCT06236243?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Korean Red Ginseng Extract Powder 120 mg/tablet (DIETARY_SUPPLEMENT), Korean Red Ginseng Extract Powder 500 mg/tablet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06236243?
This trial is sponsored by Korea Ginseng Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06236243 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06236243's enrollment target sits among peer trials
108 190th of 300 higher than 111 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI